Living With: Podcast Interview with Daniel Malito
Daniel Malito is an advocate on two of Health Union’s communities: RheumatoidArthritis.net and Blood-Cancer.com. I had the opportunity to interview …
Emily Downward
Living With: An Interview with Advocate Ronni Gordon
Ronni Gordon, an advocate here on Blood-Cancer.com, was recently interviewed for the Health Union podcast Living With. Ronni was diagnosed …
Research Shows Cancer Likely to Become More Deadly than Heart Disease
Heart disease is the leading cause of death in Americans, but new research shows that cancer is likely to surpass …
FDA Approves First Biosimilar to Rituxan & New Drug for AML
On November 28, 2018, the U.S. Food and Drug Administration (FDA) approved two new products that affect the blood cancer …
FDA Approves 2 New Treatments for AML in Older Adults & Patients with Comorbidities
The U.S. Food and Drug Administration (FDA) recently approved two new treatment options for certain people with acute myeloid leukemia …
Precision Medicine Research in Blood Cancer
I recently attended a fascinating discussion in precision medicine in cancer care. Precision medicine is the tailoring of treatment for …
FDA Approves New Immunotherapy Combination for Multiple Myeloma
The U.S. Food and Drug Administration (FDA) recently approved Empliciti® (elotuzumab) as part of a combination treatment to treat certain …
What’s CD1 Got To Do With It?
CD1, or cyclin D1, is a protein that is involved with cell development and growth. All cells grow and divide, …
FDA Approves First Next-Generation Sequencing Test for Minimal Residual Disease of ALL and Multiple Myeloma
On September 28, 2018, the U.S. Food and Drug Administration (FDA) approved the first next-generation sequencing-based test to detect very …
FDA Approves Copiktra for CLL/SLL and Follicular Lymphoma
On September 24, 2018, the U.S. Food and Drug Administration (FDA) approved a new treatment for certain types of blood …
What is Mantle Cell Lymphoma?
Mantle cell lymphoma is a rare form of non-Hodgkin lymphoma (NHL) that arises from B cell lymphocytes, a type of …
FDA Approves Lumoxiti for Hairy Cell Leukemia
On September 13, 2018, the U.S. Food and Drug Administration (FDA) approved a new treatment option for adults with hairy …
Life with Lymphoma: Highlights from our 2018 Blood Cancer In America Survey
Of those who responded to our 2018 Blood Cancer In America survey, 32% were impacted by lymphoma, a type of …
The Fears & Worries of Life with Blood Cancer
In our 2018 Blood Cancer In America survey, people living with blood cancer shared their perspective on how the condition …
Differences in Blood Cancer Experience
In our 2018 Blood Cancer In America survey, over 2,500 people impacted by blood cancer shared their experiences about diagnosis, …
FDA Expands Venclexta Approval for Broader Treatment of CLL and SLL
The U.S. Food and Drug Administration (FDA) has recently expanded the approval for Venclexta® (venetoclax). Venclexta is now approved to …
Psychosocial Considerations for Children with Cancer
A diagnosis of cancer carries a psychosocial and physical impact for anyone, and for the youngest patients, there are added …
Expanded Approval for Darzalex – Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
The U.S. Food and Drug Administration (FDA) has recently expanded the usage of Darzalex® (daratumumab): it is now approved to …
CAR T-Cell Therapy Kymriah Now Approved for Adult Diffuse Large B-Cell Lymphoma
The U.S. Food and Drug Administration (FDA) recently expanded the approval of Kymriah™ (tisagenlecleucel) to include adults with diffuse large …